Tumor Necrosis Factor Receptor Superfamily Member 18 Market Report

Global and Region Tumor Necrosis Factor Receptor Superfamily Member 18 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：166
  • REPORT CODE：GMM1004413
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tumor Necrosis Factor Receptor Superfamily Member 18 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Necrosis Factor Receptor Superfamily Member 18market, defines the market attractiveness level of Tumor Necrosis Factor Receptor Superfamily Member 18 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tumor Necrosis Factor Receptor Superfamily Member 18 industry, describes the types of Tumor Necrosis Factor Receptor Superfamily Member 18 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Necrosis Factor Receptor Superfamily Member 18 market and the development prospects and opportunities of Tumor Necrosis Factor Receptor Superfamily Member 18 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Necrosis Factor Receptor Superfamily Member 18 market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb Company

    • Ablynx NV

    • Novartis AG

    • Merck & Co Inc

    • OncoMed Pharmaceuticals Inc

    • Regeneron Pharmaceuticals Inc

    • Amgen Inc

    • Five Prime Therapeutics Inc

    • Apogenix GmbH

    • MedImmune LLC

    • Incyte Corp

    By Type:

    • AMG-228

    • BMS-986156

    • FPA-154

    • GWN-323

    • INCAGN-1876

    • Others

    By End-User:

    • Melanoma

    • Non-Small Cell Lung Cancer

    • Gastric Cancer

    • Blood Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tumor Necrosis Factor Receptor Superfamily Member 18 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis and Outlook to 2022

    • 7.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.4 China Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.5 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.6 India Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    • 7.7 South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption (2017-2022)

    8 Region and Country-wise Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis and Outlook to 2028

    • 8.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.4 China Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.5 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.6 India Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    • 8.7 South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast (2022-2028)

    9 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Outlook by Types and Applications to 2022

    • 9.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AMG-228 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global BMS-986156 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global FPA-154 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global GWN-323 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global INCAGN-1876 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Melanoma Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastric Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Outlook by Types and Applications to 2028

    • 10.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AMG-228 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global BMS-986156 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global FPA-154 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global GWN-323 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global INCAGN-1876 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Details

      • 14.1.2 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.2 Ablynx NV

      • 14.2.1 Ablynx NV Company Details

      • 14.2.2 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.4 Merck & Co Inc

      • 14.4.1 Merck & Co Inc Company Details

      • 14.4.2 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.5 OncoMed Pharmaceuticals Inc

      • 14.5.1 OncoMed Pharmaceuticals Inc Company Details

      • 14.5.2 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.6 Regeneron Pharmaceuticals Inc

      • 14.6.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.6.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.7 Amgen Inc

      • 14.7.1 Amgen Inc Company Details

      • 14.7.2 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.8 Five Prime Therapeutics Inc

      • 14.8.1 Five Prime Therapeutics Inc Company Details

      • 14.8.2 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.9 Apogenix GmbH

      • 14.9.1 Apogenix GmbH Company Details

      • 14.9.2 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.10 MedImmune LLC

      • 14.10.1 MedImmune LLC Company Details

      • 14.10.2 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • 14.11 Incyte Corp

      • 14.11.1 Incyte Corp Company Details

      • 14.11.2 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tumor Necrosis Factor Receptor Superfamily Member 18

    • Figure Tumor Necrosis Factor Receptor Superfamily Member 18 Picture

    • Table Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption by Country (2017-2022)

    • Figure United States Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Table Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Figure China Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Figure Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Figure India Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast by Country (2022-2028)

    • Figure United States Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AMG-228 Consumption and Growth Rate (2017-2022)

    • Figure Global BMS-986156 Consumption and Growth Rate (2017-2022)

    • Figure Global FPA-154 Consumption and Growth Rate (2017-2022)

    • Figure Global GWN-323 Consumption and Growth Rate (2017-2022)

    • Figure Global INCAGN-1876 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Melanoma Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AMG-228 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BMS-986156 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FPA-154 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GWN-323 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global INCAGN-1876 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tumor Necrosis Factor Receptor Superfamily Member 18 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tumor Necrosis Factor Receptor Superfamily Member 18 Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Ablynx NV (Foundation Year, Company Profile and etc.)

    • Table Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table OncoMed Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Five Prime Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Apogenix GmbH (Foundation Year, Company Profile and etc.)

    • Table Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table MedImmune LLC (Foundation Year, Company Profile and etc.)

    • Table MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service

    • Table Incyte Corp (Foundation Year, Company Profile and etc.)

    • Table Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US